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A new plum pox potyvirus (PPV)-based vector has been constructed for the expression of full-length individual foreign
proteins. The foreign sequences are cloned between the NIb replicase and capsid protein (CP) cistrons. The heterologous
protein is split from the rest of the potyviral polyprotein by cleavage at the site that originally separated the NIb and CP
proteins and at an additional NIa protease recognition site engineered at its amino-terminal end. This vector (PPV–NK) has
been used to clone different genes, engendering stable chimeras with practical applications. We have constructed a chimera
expressing high levels of jellyfish green fluorescent protein, which can be very useful for the study of PPV molecular biology.
The VP60 structural protein of rabbit hemorrhagic disease virus (RHDV) was also successfully expressed by making use of
the PPV–NK vector. Inoculation of extracts from VP60-expressing plants induced a remarkable immune response against
RHDV in rabbits, its natural host. Moreover, these animals were protected against a lethal challenge with RHDV. © 2001
Academic Press
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Plum pox virus (PPV) belongs to the Potyvirus genus of
lant viruses. Potyviruses have a single-stranded RNA
enome of positive sense. This is translated into a single
olyprotein that is further processed by viral-coded pro-
eases (Riechmann et al., 1992). The potyviral genomic
NA is surrounded by approximately 2000 units of a
ingle type of capsid protein (CP) that is encoded at the
nd of the genome, forming helicoidal virions (Shukla et
l., 1994).
The interest of using plants, and particularly plant virus
ectors, for the expression of foreign proteins has led to
he development of viral vectors based in different types
f plant viruses (Johnson et al., 1997; Scholthof et al.,
996). Expression of proteins that could function as an-
igens for active immunization, using a plant virus, has
een mostly restricted to expression of antigenic pep-
ides fused to the capsid protein. However, a tobacco
osaic virus-based vector expressing the vp1 structural
rotein of the foot-and-mouth disease virus has recently
een described. Mice immunized with extracts from
icotiana tabacum plants infected with this chimeric
irus developed an effective immune response (Wigdoro-
itz et al., 1999).
Potyviral-based vectors for the expression of full-
ength independent proteins have been previously de-p
r
1 To whom correspondence should be addressed. Fax: 34-1-
854506. E-mail: jagarcia@cnb.uam.es.
283cribed. The first was developed based on tobacco etch
irus (Dolja et al., 1992). Afterward, similar vectors were
eveloped based on other potyviruses (Choi et al., 2000;
erman-Retana et al., 2000; Guo et al., 1998; Masuta et
l., 2000; Varrelmann and Maiss, 2000). These potyviral
ectors seemed to be impaired in replication efficiency
nd genome stability in most of the cases in which these
arameters were assessed (Choi et al., 2000; Dolja et al.,
993; German-Retana et al., 2000; Guo et al., 1998; Ma-
uta et al., 2000).
Rabbit hemorrhagic disease is a rapidly lethal infec-
ion of adult animals. Infected rabbits usually die within
8 to 72 h of necrotizing hepatitis. The causing agent of
he disease, Rabbit hemorrhagic disease virus (RHDV), is
member of the family Caliciviridae (Ohlinger et al.,
990; Parra and Prieto, 1990). Commercial vaccines
gainst viral hemorrhagic disease of rabbits are pro-
uced from tissues, such as spleen and liver, collected
rom experimentally infected SPF rabbits, due to the fact
hat, to date, a permissible stable cell line allowing RHDV
eplication has not been described. In recent years,
P60—the major structural protein of RHDV—has been
roduced in several heterologous systems (Barcena et
l., 2000; Bertagnoli et al., 1996a; Boga et al., 1994;
ischer et al., 1997; Laurent et al., 1994; Marı´n et al., 1995;
agesha et al., 1995; Plana-Duran et al., 1996; Sibilia et
l., 1995), including transgenic potato plants (Castan˜o´n
t al., 1999), and in all cases the recombinant VP60
rotein obtained has been shown to induce protection of
abbits against a lethal challenge with RHDV.
0042-6822/01 $35.00
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284 FERNA´NDEZ-FERNA´NDEZ ET AL.In this paper we describe the construction of a new
PPV-based vector (PPV–NK) that expresses the protein of
interest between the NIb replicase and CP sequences. A
chimera expressing green fluorescent protein (GFP) was
constructed and it was found to be highly stable. More-
over, VP60, the structural protein of RHDV, has been
expressed with the PPV–NK vector. Immunization of the
natural host of RHDV (rabbits) with extracts of Nicotiana
clevelandii plants infected with the PPV–NK–VP60 chi-
mera induced an efficient immune response that pro-
tected animals against a lethal challenge with RHDV.
RESULTS
Construction of the PPV-based expression vector
PPV–NK
FIG. 1. (A) Strategy followed to construct the PPV–NK vector and to
where modifications were made is shown. Solid boxes represent eng
protease recognition sites is represented by transversal grids, and the
NIb and CP sequences in the PPV–NK vector. The nucleotide sequence
The amino acid sequence is shown in capital letters. The NIb and CP
is boxed and the scissile bond is indicated by a solid triangle.A PPV-based-vector for the expression of full-length
independent foreign proteins, PPV–NK, was constructed.
q
qIn this vector, the foreign sequences were cloned be-
tween the NIb replicase and CP cistrons. The cloning
was designed to avoid the modification of any sequence
of the viral proteins, with an interest in interfering as little
as possible with any viral function. The NIb/CP region of
the PPV polyprotein encoded by pICPPV–NK consists of
(i) an intact NIb protein, but one whose terminal six
amino acids (that form part of the sequence recognized
by the NIa protease) are encoded by a modified nucle-
otide sequence; (ii) five amino acids, including the Ala
residue present at the 11 position of the natural NIb/CP
leavage site, encoded by a nucleotide sequence that
ontains the NaeI restriction site, a spacer sequence,
nd a KpnI restriction site (NaeI and KpnI are unique in
ICPPV–NK); (iii) again the six carboxy-terminal amino
cids of the NIb protein (encoded by the original se-
oreign genes in it. A detail of the region of the wild-type PPV genome
d restriction sites and spacing sequences. Sequence coding for NIa
bond is marked by a solid triangle. (B) Detail of the junction between
wn in lowercase letters, and NaeI and KpnI restriction sites are boxed.
ces are underlined. The heptapeptide recognized by the NIa proteaseclone f
ineere
scissile
is shouence); and (iv) CP. The NIa protease recognition se-
uence engineered has the same amino acid sequence
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285RHDV IMMUNIZATION WITH VP60 VIA A PPV-BASED VECTORas the original NIb/CP site, but it is encoded by a se-
quence in which the third nucleotide of each codon has
been changed to hinder recombination events (Fig. 1B).
Full-length cDNA of PPV is cloned in pICPPV–NK-
derived plasmids under the control of an enhanced cau-
liflower mosaic virus 35S promoter and holds a nopaline
synthase termination signal, which allow the production
of viral transcripts in vivo in plants of N. clevelandii
directly inoculated with DNA (Lo´pez-Moya and Garcı´a,
2000). pICPPV–NK was able to infect plants with an
efficiency similar to that of nonmutated pICPPV. The time
course of infection and symptomatology were similar to
those of wild-type PPV-infected plants. Western blot anal-
ysis confirmed that the level of accumulation of PPV–NK
was similar to that of wild-type PPV and that, since no
differences in the electrophoretic mobility of CP were
observed, at least the NIa recognition heptapeptide
closer to CP was fully processed (data not shown). Im-
munocapture RT–PCR (IC–PCR) amplification from the
infected plants of a cDNA fragment of the mutated region
revealed, as expected, a band with a lower mobility than
that amplified from wild-type PPV. The fragment amplified
from the PPV–NK-infected plants conserved the original
sequence, as determined by NaeI and KpnI digestion
nd nucleotide sequencing (data not shown).
onstruction of a PPV chimera carrying a gfp
eporter gene
The ease of detection of GFP activity and the expected
alue of a PPV–GFP chimera as a tool for the study of
PV molecular biology prompted us to choose GFP for a
irst attempt at expressing a heterologous protein with
he PPV–NK vector. pICPPV–NK–GFP, constructed as ex-
lained under Materials and Methods, was directly inoc-
lated in N. clevelandii plants, resulting in a high per-
entage of infected plants, similar to that of plants inoc-
lated with pICPPV or pICPPV–NK. The time course of
FIG. 2. Western blot analysis of extracts from N. clevelandii plants
infected with wild-type PPV (lanes 1 and 3) and PPV–NK–GFP (lanes 2
and 4), using anti-PPV 5B MAb (lanes 1 and 2) and anti-GFP MAb
mixture (Roche Molecular Biochemicals) (lanes 3 and 4). The sizes in
kDa of prestained molecular weight markers (Bio-Rad) run in the same
gel are indicated beside the panel.nfection and symptomatology were similar to those ob-
erved in plants infected with wild-type PPV.Western blot analysis showed the same electro-
horetic mobility for CP accumulated in systemically
nfected leaves from plants inoculated with PPV–NK–
FP or with wild-type PPV (Fig. 2, lanes 2 and 1). This
onfirms that cleavage between GFP and CP is taking
lace efficiently. On the other hand, in crude extracts
rom PPV–NK–GFP-infected leaves, we were also able to
etect GFP by Western blot (Fig. 2, lane 4). The protein
howed the expected mobility. No products of lower or
igher mobility were observed, ruling out both an ineffi-
ient processing between NIb and GFP and the gener-
tion of deletions in the sequence coding for the foreign
rotein. The autofluorescence of GFP protein was easily
etected by confocal or epifluorescence microscopy in
eaves infected with the chimeric virus even before mac-
oscopic symptoms of infection were evident (data not
hown).
To confirm the genetic stability of the chimera, a cDNA
ragment including the foreign sequence was amplified
y IC–PCR from extracts of leaves infected with PPV–
K–GFP. The amplified fragments had the expected size,
arger than those amplified from wild-type PPV-infected
lants (Fig. 3, lanes 3 to 8 compared to lane 9). Moreover,
o smaller DNA fragments could be detected, further
ndicating that deleted forms arising from instability of
he chimera were not being generated during virus rep-
ication in the plant.
Virus and GFP accumulations were quantified in in-
ected N. clevelandii plants by ELISA using purified viri-
ns and commercial recombinant GFP (Roche Molecular
iochemicals) as standards. Virus accumulation levels in
lants infected with wild-type PPV and PPV–NK–GFP
38.8 6 3.9 and 63 6 6.9 mg per 100 g of infected leaf
issue, respectively) seemed to be only slightly higher
FIG. 3. IC–PCR analysis of extracts from N. clevelandii plants in-
fected with PPV–NK–GFP chimeric virus after a plant passage from the
progeny (lanes 3 to 8) or with wild-type PPV (lane 9), 30 dpi, and from
a mock-inoculated plant (lane 1) (the amplified fragments correspond to
nt 8390 to 8900 in the wild-type PPV genome). Molecular weights of
HindIII restriction fragments of phage ø29 DNA used as size markers
(lane 2) are indicated beside the panel.
pE
286 FERNA´NDEZ-FERNA´NDEZ ET AL.than GFP accumulation in these latter plants (25 6 2 mg
er 100 g of leaf tissue).
xpression of RHDV structural protein VP60 in N.
clevelandii plants
To test the possibility of using the PPV–NK vector to
produce in plants antigenic proteins useful for active
immunization, we constructed a chimera that expressed
the VP60 structural protein from RHDV. pICPPV–NK–
VP60 was able to infect N. clevelandii plants with similar
efficiency to that of pICPPV. The symptomatology and
time course of PPV–NK–VP60 infection were similar to
those of wild-type PPV infection. The VP60 protein was
easily detected by Western blot analysis at 15 days
postinoculation (dpi), reaching higher accumulation lev-
els at 21 dpi (Fig. 4). Fifteen days postinfection no other
band apart from that of the full-length protein was de-
tected in the Western blot assays reacting with anti-VP60
(data not shown); however, 21 dpi bands with electro-
phoretic mobilities corresponding to those of truncated
proteins of approximately 38 kDa (plant 1), 44 kDa (plant
9), and 46 and 33 kDa (plant 15) were apparent in the
anti-VP60 Western blot (Fig. 4). Although we cannot rule
out that some of these bands correspond to degraded
protein, it is probable that they were mainly the result of
some instability of the chimeric genome. This assump-
tion was supported by the detection of partial deletions
of the foreign sequence in a virus cDNA fragment am-
plified by IC–PCR from infected tissue (data not shown).
In any case, the full-length VP60 was the predominant
form in most plants, demonstrating the capability of the
system to efficiently express rather large proteins of
interest.
Immunization of rabbits with extracts from PPV–NK–
VP60-infected plants and protection against
a RHDV challenge
The immunogenicity of the VP60 protein expressed
FIG. 4. Western blot analysis of extracts from N. clevelandii plants
inoculated with PPV–NK–VP60 (lanes 1 to 15) or with wild-type PPV
(lane 16) using a polyclonal serum against RHDV VP60. Plants in lanes
3, 5, 8, and 14 were symptomless (data not shown). Bands in lanes 3
and 8 are probably due to leakage from flanking wells. The sizes in kDa
of prestained molecular weight markers (Bio-Rad) run in the same gel
are indicated beside the panel.in plants with the PPV–NK vector was studied in the
natural host of RHDV, rabbits. Twenty-seven days afterthe first antigen administration, serum samples were
analyzed for the presence of specific antibodies by the
hemagglutination inhibition (HI) test (Table 1). Nine of
10 rabbits of group I (vaccinated with extracts from
plants infected with PPV–NK–VP60 expressing the full-
length VP60) exhibited VP60-specific antibodies with
variable titers, ranging from 1/20 to 1/320. Similar
titers were observed in all the animals from group III
(vaccinated with extract from an infected plant accu-
mulating an approximately 44-kDa deleted form in
addition to the full-length VP60). Three of 4 rabbits
from group II (vaccinated with extract from a plant
primarily accumulating an approximately 38-kDa de-
leted form of VP60) gave a lower specific serological
response (titers of 1/20 to 1/40). The antibody re-
sponse was somehow higher and more homogeneous
in the cases of animals vaccinated with the commer-
cial vaccine CYLAP HVD (group V) (with animals show-
ing titers of 1/320 to 1/640). As expected, animals
vaccinated with wild-type PPV-infected plant extracts
(group IV) and nonvaccinated control animals (group
VI) did not show specific antibodies against RHDV.
Thirty-three days after the initial immunization (D33),
all the animals were given a booster using extracts
with the same characteristics as those of the originals.
On D67, the antibody titers were analyzed by HI test
and a lethal challenge was performed. While control
groups (IV and VI) remained negative, the serological
response increased in all the other vaccination
groups. Again, the highest titers were observed in
groups vaccinated with CYLAP HVD and exclusively
the complete VP60 (groups V and I), followed by
groups vaccinated with extracts from plants
accumulating VP60-deleted forms (group III being bet-
ter than group II).
The challenge was adequate because the mortality
rate due to RHDV in the group vaccinated with the
wild-type PPV-infected plant and in the nonvaccinated
control group was 100%, and RHDV was detected in
their livers (Table 1). During the experimental infection
period with the virulent RHDV, while all except one of
the animals from control groups IV and VI died within
3 days after challenge, no clinical symptoms of the
disease were observed in animals vaccinated with
CYLAP HVD (group V) or with PPV–NK–VP60-infected
plants (groups I, II, and III). Two weeks after challenge,
surviving animals were bled and slaughtered. In gen-
eral, antibody titers of surviving animals, determined
by HI test, were higher 2 weeks after challenge (Table
1). No RHDV was detected in the livers of surviving
animals. Therefore, it can be concluded that animals
vaccinated with extracts from plants expressing the
VP60 protein developed an efficient humoral immune
response and were protected against a lethal chal-
lenge with RHDV.
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Plants that have traditionally been used as sources of
ood, fibers, and fuel are now being considered as alter-
ative factories for the production of molecules of inter-
st, with low expenses, high biological security, and
T
Antibody Titers against
Groupa Animal No.
HI titers
D27c
I
PPV–NK–VP60 (full-length
VP60, plants 2, 4, 6, 7, 11,
13)
818 1/320
821 1/160
822 1/80
823 1/80
826 1/20
827 1/20
831 ,1/20
834 1/40
837 1/80
897 1/160
I
PV–NK–VP60D1 (full-length
VP60 and ;38-kDa deleted
form from plant 1)
845 1/40
846 ,1/20
847 1/40
848 1/20
II
PV–NK–VP60D9 (full-length
VP60 and ;44-kDa deleted
form from plant 9)
839 1/20
840 1/320
842 1/20
844 1/40
V
PV–wt (no insertion, plant 16) 900 ,1/20 ,
809 ,1/20 ,
813 ,1/20 ,
816 ,1/20 ,
YLAP HVD (Fort Dodge
vaccine)
851 1/320
853 1/320
854 1/640
855 1/320
I
ontrol (nonvaccinated) 804 ,1/20 ,
824 ,1/20
825 ,1/20
863 ,1/20 ,
864 ,1/20 ,
866 ,1/20 ,
a Plant numbering according to that in Fig. 4.
b HI test: rabbit sera antibody level against RHDV was determined
seronegative to RHDV at D0 (HI titers ,1/20).
c Rabbits were vaccinated on day 0 (D0), bled on D27, given a boost
animals (S) were bled and slaughtered 2 weeks after challenge (DY 1
d HA test: presence of RHDV was determined by hemagglutination oase in manipulation (Arntzen, 1997). The use of plant
irus-based vectors instead of transgenic plants for the
l
production of novel proteins presents several advan-
ages (Arntzen, 1997; Scholthof et al., 1996), although
oth systems are of great value under different circum-
tances.
The first vectors developed for the expression of full-
and Challenge Results
Challenge results
Death HI titers DY 1 15 HA titers liver samplesd
S 1/10,240 ,2
S 1/5,120 ,2
S 1/2,560 ,2
S 1/5,120 ,2
S 1/5,120 ,2
S 1/160 ,2
S 1/2,560 ,2
S 1/2,560 ,2
S 1/5,120 ,2
S 1/2,560 ,2
S 1/5,120 ,2
S 1/1,280 ,2
S 1/640 ,2
S 1/1,280 ,2
S 1/640 ,2
S 1/5,120 ,2
S 1/10,240 ,2
S 1/2,560 ,2
DY 1 3 $4096
DY 1 3 $4096
DY 1 3 $4096
DY 1 3 $4096
S 1/10,240 ,2
S 1/5,120 ,2
S 1/10,240 ,2
S 1/10,240 ,2
DY 1 3 $4096
DY 1 3 $4096
DY 1 3 $4096
DY 1 5 $4096
DY 1 3 $4096
DY 1 3 $4096
agglutination inhibition test of human red blood cells. Rabbits were
33, bled again (D67), and challenged (DY) on the same day. Surviving
n red blood cells. Titers ,2 were considered negative.ABLE 1
RHDV
b
D67
1/2560
1/2560
1/640
1/1280
1/640
1/320
1/1280
1/160
1/640
1/5120
1/320
1/160
1/320
1/320
1/320
1/1280
1/640
1/640
1/20
1/20
1/20
1/20
1/5120
1/2560
1/2560
1/640
1/20
1/20
1/20
1/20
1/20
1/20
by hem
er on Dength independent proteins, based on potyviruses, ex-
lored the genomic region between the P1 and HC
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288 FERNA´NDEZ-FERNA´NDEZ ET AL.cistrons as the site of insertion of foreign sequences
(Dolja et al., 1992; German-Retana et al., 2000; Guo et al.,
998). Although these have been of great value in the
tudy of the molecular biology of potyviruses and other
lant viruses (for instance, Carrington and Whitham,
998; Dolja et al., 1997; Kasschau et al., 1997; Verchot
nd Carrington, 1995; Whitham et al., 1999), their utility
or overproduction of proteins of interest could be limited
y the susceptibility of foreign sequences expressed in
hem to suffer deletions under certain circumstances
Choi et al., 2000; Dolja et al., 1993, 1997; German-Retana
t al., 2000; Guo et al., 1998). A notable decrease in
replication efficiency and/or pathogenicity has also been
observed in most of these virus vectors.
A chimeric PPV containing the gus gene cloned be-
tween the NIb and CP cistrons has been reported; ter-
minal sequences of these cistrons were duplicated, re-
sulting in the production of a GUS protein fused to the 27
amino-terminal amino acids of CP and the 18 carboxy-
terminal amino acids of NIb (Varrelmann and Maiss,
2000). No data are available on the biological perfor-
mance or the genomic stability of this chimeric clone,
although a very rapid loss of the foreign sequences
cloned between duplicated viral sequences has been
reported in other systems (Dawson et al., 1989; Donson
et al., 1991). Recently, a vector based in wheat streak
virus, a member of the genus Tritimovirus, with a genome
organization typical of the family Potyviridae, has been
developed (Choi et al., 2000). The stability of chimeras
based in this virus, which uses the NIb/CP junction as
the insertion site, appears to depend on the gene in-
serted and the host used. The vector that we have con-
structed, PPV–NK, also uses the NIb/CP junction as the
cloning site, but avoids duplication of viral sequences.
The cloning strategy warrants that foreign proteins ex-
pressed with this vector only have one additional amino
acid in the amino end and eight extra amino acids in the
carboxyl end to ensure proteolytic processing. The se-
quence encoding GFP was shown to be stable when
cloned in pICPPV–NK–GFP. In the case of the sequence
encoding VP60, cloned in pICPPV–NK–VP60, it was also
quite stable, although deleted forms appear at late times
postinfection in some plants. It has been reported that
genomic instability of tobacco mosaic virus-derived chi-
meras seems to rise with the size of the foreign insert
(Donson et al., 1991). Thus, the larger size of the VP60
gene (1737 nt) with respect to that of the gfp gene (716 nt)
could account for its lower stability. However, differences
in the suitability for recombination of the foreign se-
quences, as well as selective pressure derived from
effects of the foreign products on virus fitness, might also
be crucial to determine the stability of the cloned genes.
An expected advantage of viral vectors with genomic
expression through single polyproteins is that all pro-
teins, including the foreign one, are synthesized in the
same quantity, and differences in accumulation levelswill depend exclusively on their stability in the infected
plants. GFP seems to be quite a stable protein and,
according to ELISA data, accumulates in PPV–NK–GFP-
infected plants at high levels, similar to those of the viral
CP, in spite of the high stability that virion assembly
confers on CP. It is also important to note that inclusion
of the gfp gene in the PPV genome does not seem to
negatively affect virus accumulation and that a slightly
higher CP amount was observed in PPV–NK–GFP-
infected plants compared to that in plants infected with
wild-type PPV. The first plant virus chimera expressing
GFP was derived from potato virus X and has proven to
be very useful in the analysis of the mechanism of
infection of this virus (Baulcombe et al., 1995). Thus, in
addition to its relevance as a paradigm of the suitability
of PPV–NK as an expression vector, PPV–NK–GFP is of
specific interest as a tool for the study of PPV molecular
biology.
This paper reports the first evidence of the use of a
potyviral-based vector for the expression of an antigenic
foreign protein capable of conferring protection on host
animals (rabbits) against a viral disease. RHD is respon-
sible for high economic losses in rabbitries and high
mortality rates in wild rabbit populations (Barcena et al.,
2000). For this reason the development of alternatives to
classic vaccines has become a focus of interest. It is
especially important to produce highly effective, low-cost
and low-risk vaccines. In this regard, plants expressing
foreign antigens become a very attractive system to
explore. RHDV VP60 had been previously expressed in
potato plants (Castan˜o´n et al., 1999) using a transgenic
approach. Although the results were very promising,
transgenic plants have certain constraints that the use of
viral vectors overcomes. Plant virus-based vectors usu-
ally allow the production of higher and more reproduc-
ible amounts of the protein of interest, manipulation
techniques are easier, proteins deleterious to the plant
can be produced without the requirement of complex
inducible promoters, and the time necessary to get the
protein of interest is shorter. Although we have not made
a precise quantification of the levels of VP60 accumula-
tion in plants infected with PPV–NK–VP60, they seem to
be quite high and the protein is easily detected by West-
ern blot in crude extracts.
The serological responses of animals vaccinated with
plant extracts producing full-length VP60, although
somewhat less homogeneous, were almost as high as
those of animals treated with the commercial CYLAP
HVD vaccine. Thus, the presence of one additional
amino acid in the N-terminus and eight in the C-terminus
of the recombinant VP60 apparently did not affect sub-
stantially the antigenicity of the protein. Interestingly,
extracts not only from plants that accumulate mainly
full-length VP60 but also from plants in which most of the
VP60 is in deleted forms were able to elicit a notable
antibody response and confer protection against RHDV.
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289RHDV IMMUNIZATION WITH VP60 VIA A PPV-BASED VECTORIf deletions in the VP60 sequence enhance the stability of
the parental chimera, the demonstration that truncated
forms of the protein could be effective immunogens
opens a way to improve the present system that should
be further analyzed.
Vaccinated animals need to exhibit HI titers in serum
of at least 1/80 to ensure protection against a lethal
challenge with RHDV (M.M. and J.P.-D., unpublished
data). Thus, approximately half of the animals immunized
with plant extracts containing full-length VP60 alone or
with its 44-kDa truncated form were expected to be
efficiently protected after administration of the first dose
of vaccine. However, since some animals had titers be-
low 1/80 after the first vaccination, a booster was needed
to warrant protection of the entire group of rabbits.
We have demonstrated that two doses of 1 ml of
extract of plants infected with PPV–NK–VP60, which rep-
resents approximately 2 g of fresh leaves, were enough
to confer on animals full protection. Making a space and
time quantification, merely 1 m2 of greenhouse space
nd 21 days are sufficient to obtain enough material to
mmunize and fully protect 50 rabbits against RHDV.
Both RHDV-like particles (Plana-Duran et al., 1996) and
vaccinia–RHDV recombinant virus (Bertagnoli et al.,
996b) were shown to protect against RHDV when they
ere administered by the oral route. Taking into account
he amount of VP60 produced in plants infected with
PV–NK–VP60 and the positive results obtained in the
mmunization experiments reported in this paper, the
evelopment of oral vaccines against RHDV in edible
PV hosts infected with PPV–NK–VP60 appears now as
n appealing challenge.
MATERIALS AND METHODS
onstruction of pICPPV–NK
pICPPV–NK was constructed according to the following
trategy (Fig. 1A). An intermediate clone designed as
GPPV–MK was constructed by the PCR-based mutagen-
sis method described by Herlitze and Koenen (1990). In
ddition to the mutagenic oligodeoxinucleotide (oligo) mMK
59 CAACAACGTTGGTACCCCGACGCGTGGACTCACCA
39), two flanking oligos, which contained the direct PPV
equence from nt 8067 to 8082 and the reverse PPV se-
uence from nt 9114 to 9127 [numbering is according to
aı´n et al. (1988)] were used for the PCR amplifications. The
utagenic oligo created MluI and KpnI unique restriction
ites (underlined in the above oligo sequence). The result-
ng PCR product was digested with ClaI and SacI and
ntroduced into the full-length clone pGPPV (Riechmann et
l., 1990) by triple ligation using SalI as the third enzyme.
he accuracy of the PCR-derived sequence was verified by
equencing of the full-length clone.
The BamHI–SacI fragment of pGPPV–MK containing the
K mutation was subcloned in pUC18 to aid the following
loning steps. Hybridization of partially complementary oli-
p
tos 59 ATGTCGTAGTACATCAGGCCGGCCGGGGTAC 39
and 39 TACAGCATCATGTAGTCCGGCCGGCCC 59 (restric-
tion sites are underlined) created a DNA fragment that held,
from 59 to 39, the coding sequence for a NIa protease
recognition site and a NaeI restriction site. This DNA frag-
ment, which had a blunt 59 end and a cohesive 39 end
compatible with KpnI, was inserted into pUC18–MK di-
gested with MluI, treated with mung bean nuclease to
remove the resulting protruding ends and with KpnI, and
yielded pUC18–NK. The accuracy of the construction was
verified by sequencing. pICPPV–NK was obtained by re-
placing the ClaI–SacI fragment (PPV nt 8310–9021) of
pICPPV, a plasmid that contains the full-length PPV cDNA
sequence placed under the control of the cauliflower mo-
saic virus 35S promoter (Lopez-Moya and Garcı´a, 2000),
with the corresponding fragment of pUC18–NK by a triple
ligation that used SalI as the third enzyme.
Cloning of foreign sequences in the pICPPV–NK
plasmid
The reporter gene gfp was amplified by PCR, using as
rimers the oligos 59 ATGGTGAGCAAGGGCGAG 39 and
9 CAGGTACCCTTGTACAGCTCGTC 39 (a KpnI restriction
site is created and is underlined in the sequence of the
oligo). The PCR product was digested with KpnI and
loned in pUC18–NK digested with NaeI and KpnI, giving
ise to pUC18–NK–GFP. pICPPV–NK–GFP was obtained
y replacing the ClaI–SacI fragment (PPV nt 8310–9021)
of pICPPV with the corresponding fragment of pUC18–
NK–GFP by a triple ligation that used SalI as the third
enzyme. The sequence coding for the RHDV VP60 struc-
tural protein was amplified by PCR using as primers the
oligos 59 ATGGAGGGCAAAGCCCGC 39 and 59 CAGG-
TACCGACATAAGAAAAGCC 39 (a KpnI restriction site is
created and is underlined in the sequence of the oligo).
The VP60–PCR product was digested with KpnI and
loned in pUC18–NK digested with NaeI and KpnI, giving
ise to pUC18–NK–VP60. The EcoRV–KpnI fragment of
UC18–NK–VP60 was introduced into pICPPV–NK by a
riple ligation using XhoI as the third enzyme, giving rise
o pICPPV–NK–VP60.
lant inoculation
For plant inoculation, full-length cDNA clones pICPPV,
ICPPV–NK, pICPPV–NK–GFP, and pICPPV–NK–VP60
ere diluted in 5 mM sodium phosphate, pH 7.5, to a
oncentration of between 100 and 500 ng/ml. Ten micro-
iters of the diluted samples was used to inoculate three
eaves per plant of N. clevelandii.
estern blot analysis
Samples from infected plants homogenized in 5 mM
odium phosphate, pH 7.5, were separated by SDS–
olyacrylamide gel electrophoresis, transferred to a ni-
rocellulose membrane, and subjected to immunoreac-
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290 FERNA´NDEZ-FERNA´NDEZ ET AL.tion as previously described (Garcı´a et al., 1992). The
anti-PPV monoclonal antibody (MAb) mixture Ingezyme
(INGENASA), anti-PPV MAb 5B (Durviz), a commercial
anti-GFP MAb mixture (Roche Molecular Biochemicals),
and an anti-VP60 polyclonal antibody were used as pri-
mary antibodies. The secondary antibodies were perox-
idase-conjugated goat anti-mouse or anti-rabbit IgGs
purchased from Jackson ImmunoResearch Laboratories.
The peroxidase reaction was developed either with
4-chloro-1-naphthol (Sigma) or with the ECL kit (Amer-
sham Pharmacia Biotech).
Immunocapture reverse transcription–PCR
Samples from infected plants homogenized in 5 mM
sodium phosphate, pH 7.5, were incubated for 2 h at
37°C in tubes previously coated with anti-PPV IgGs, and
then, after two washing steps with PBS–Tween buffer
(1 3 PBS, 0.5 g/L Tween 20), reverse transcription–PCR
(RT–PCR) was performed as previously described (Can-
dresse et al., 1995).
ELISA
Three leaf discs were collected from plants infected
either with wild-type PPV, or with PPV–NK–GFP or from
mock-inoculated plants. The discs were homogenized in
150 ml of carbonate buffer, pH 9.6. Two microliters of each
extract was diluted in 98 ml of carbonate buffer and applied
to 96-well plates (Maxisorp, Nunc). Increasing amounts of
recombinant GFP (Roche Molecular Biochemicals) and
PPV purified virions added to 2 ml of a healthy plant extract
ere used to make standard curves. The plates were in-
ubated overnight at 4°C. After washing twice with PBS
uffer, the wells were saturated with 1% BSA in PBS buffer
or 2 h at 37°C. The plates were then washed with PBS
uffer containing 0.5% BSA and 0.05% Tween and incu-
ated at 37°C for 3 h with anti-GFP MAb mixture (Roche
olecular Biochemicals) (1:2000 dilution) or Ingezyme anti-
PV mixture (INGENASA) (1:2000 dilution). After washing
ith PBS–BSA–Tween buffer, the plates were incubated at
7°C for 1 h with alkaline phosphatase-conjugated goat
nti-mouse IgGs (Jackson ImmunoResearch Laboratories).
fter a final washing step with PBS–BSA–Tween buffer, the
lates were developed with p-nitrophenyl phosphate
Sigma) and the optical densities of samples were deter-
ined at 405 nm.
ormulation of vaccines
Leaves from plants, infected either with wild-type PPV
r with PPV–NK–VP60, were homogenized in PBS [1:1
w/v) or 1:2 (w/v)] and cell debris were eliminated by
entrifugation. The vaccines were formulated by mixing
he antigenic phase (leaf extracts) with an oily adjuvant,
t a ratio of 53:47 (v/w), until a double water/oil/water
mulsion was formed. The oily phase consisted of a
ixture of marcol-52, simulsol-5100, and montanide-888. Bour different plant-based vaccines were prepared. Also,
commercially available inactivated purified vaccine for
he prevention of viral hemorrhagic disease of rabbits
ith oily adjuvant (CYLAP HVD, Fort Dodge Veterinaria)
as used as a control for the experiment.
emagglutination inhibition test
RHDV agglutinates human red blood cells of type O.
emagglutination (HA) is inhibited by specific antiserum.
he HI test has been used for the detection of anti-RHDV
ntibodies in serum as previously described (Pu et al.,
985).
accination of rabbits
A total of 32 New Zealand white female rabbits, 15–16
eeks old, were used in this experiment. Animals were
eronegative to RHDV by the HI test using human red
lood cells and 4 hemagglutination units (HAu) of RHDV.
he different groups (I to V) were vaccinated by the
ubcutaneous route with 1 ml of vaccine. A booster was
iven 33 days later. Animals from group VI remained
nvaccinated as negative control. Vaccinated and non-
accinated animals were bled by cardiac puncture on
ays 0, 27, and 67 postvaccination, and antibody titers
gainst RHDV were evaluated by the HI test.
hallenge of rabbits and detection of RHDV in the liver
Sixty-seven days after the first vaccination, all the
abbits (vaccinated and nonvaccinated) were challenged
y the intranasal route with 10280 HAu in 0.5 ml of PBS
f an RHDV virulent strain (equivalent to 1125 LD50). The
nimals were observed daily and deaths were monitored
ntil 15 days postinfection. Two weeks after challenge,
urviving animals were bled and slaughtered. The livers
rom all the challenged animals were frozen at 280°C
mmediately after death. Later, they were thawed, ho-
ogenized in PBS, and tested for the presence of RHDV
y HA of human red blood cells type O.
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